Caring Cross Inc
Donations deductibleRevenue
$6.4m
year to 31 December 2024
Expenses
$10.3m
year to 31 December 2024
Total assets
$16.5m
$6m liabilities
Net assets
$10.5m
assets less liabilities
Directors and trustees
16
5.7 years on average
Staff
33
14 volunteers
Left since last filing
0
no seats appear to have opened
Officers and senior staff
8
named in Part VII
Caring Cross Inc's network
16 peoplei16 people on this map.The large node is the subject of this page. Solid lines are what the register itself records (16). Form 990 filings give names without a person identifier; SEC insider filings carry a CIK.The board
16 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record. The organisation reported 15 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Barbara Savoldo MD PHD (also filed as Barbara Savoldo MD PhD) | Director | 2020 | 6 yrs |
| Boro Dropulic PHD MBA (also filed as Boro Dropulic PhD MBA) | Exec Dir., Founder, President | 2020 | 6 yrs |
| Crystal Mackall MD | Director | 2021 | 5 yrs |
| Deus Bazira Drph MPH MBA | Director | 2021 | 5 yrs |
| James Kenny MBA | Director | 2020 | 6 yrs |
| Jennifer Adair PHD (also filed as Jennifer Adair PhD) | Director | 2021 | 5 yrs |
| Joshua Speidel PHD (also filed as Joshua Speidel PhD) | Director | 2020 | 6 yrs |
| Julie Makani MD PHD Frcp Ftaas (also filed as Julie Makani MD PhD Frcp Ftaas) | Director | 2021 | 5 yrs |
| Lindsay Androski JD | Director | 2020 | 6 yrs |
| Mark Dybul MD | Director | 2020 | 6 yrs |
| Mike McCune MD PHD (also filed as Mike McCune MD PhD) | Director | 2020 | 6 yrs |
| Nicanor Austriaco OP PHD STD (also filed as Nicanor Austriaco OP PhD STD) | Director | 2021 | 5 yrs |
| Nirav Shah MD Mshp | Director | 2021 | 5 yrs |
| Rimas Orentas PHD End 92024 | Scientific Dir., Founder, Sec, Pres | 2024 | 2 yrs |
| Tom Rosedale JD (also filed as Tom Rosedale JD) | Director | 2020 | 6 yrs |
| Xiaobin LU PHD (also filed as Xiaobin Lu PhD) | Director | 2021 | 5 yrs |
Officers and senior leadership
8 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Beatrix Ferencz | Assoc. Dir. of Process Development | 2024 |
| IBE Oparaocha | Director of Process Development | 2024 |
| Kara Anlauf | Science Resources and Communications | 2024 |
| Megan Forrest | Chief Operating Officer | 2024 |
| Nikel Davis MBA | Director | 2021 |
| Oxana Slessareva | Dir. of Quality Systems Development | 2024 |
| Ying Xiong | Director of Cell & Gene Therapy | 2024 |
| Zhongyu ZHU | Chief Science Officer | 2024 |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Rimas Orentas PhD End 92024 | Scientific Dir., Founder, Sec, Pres | 40 | $227k | $23k | |
| Zhongyu Zhu | Chief Science Officer | 40 | $226k | ||
| Megan Forrest | Chief Operating Officer | 40 | $199k | $23k | |
| Beatrix Ferencz | Assoc. Dir. of Process Development | 40 | $158k | $27k | |
| Ibe Oparaocha | Director of Process Development | 40 | $153k | $8k | |
| Kara Anlauf | Science Resources and Communications | 40 | $146k | $6k | |
| Boro Dropulic PhD MBA | Exec Dir., Founder, President | 40 | $144k | $8k | |
| Ying Xiong | Director of Cell & Gene Therapy | 40 | $136k | $22k | |
| Oxana Slessareva | Dir. of Quality Systems Development | 40 | $127k | $7k | |
| Jennifer Adair PhD | Director | 5 | $0 | ||
| Lindsay Androski JD | Director | 5 | $0 | ||
| Nicanor Austriaco Op PhD STD | Director | 5 | $0 | ||
| Deus Bazira DRPH MPH MBA | Director | 5 | $0 | ||
| Mark Dybul MD | Director | 5 | $0 | ||
| James Kenny MBA | Director | 5 | $0 | ||
| Xiaobin Lu PhD | Director | 5 | $0 | ||
| Crystal Mackall MD | Director | 5 | $0 | ||
| Julie Makani MD PhD FRCP Ftaas | Director | 5 | $0 | ||
| Mike McCune MD PhD | Director | 5 | $0 | ||
| Tom Rosedale JD | Director | 5 | $0 | ||
| Barbara Savoldo MD PhD | Director | 5 | $0 | ||
| Nirav Shah MD MSHP | Director | 5 | $0 | ||
| Joshua Speidel PhD | Director | 5 | $0 |
About
- Legal name
- Caring Cross Inc
- EIN
- 815088460
- Address
- 910 Clopper Rd Ste 200s, Gaithersburg, MD, 20878-1361
- State
- Maryland
- Mission
- Caring cross is focused upon accelerating the development and implementation of advanced medicines like car-t cell and stem cell gene therapies. In partnership with like-minded stakeholders, caring cross develops and deploys technologies, systems and therapeutic candidates that improve the affordability and accessibility of these potentially life-saving therapies for all patients in need... (as filed on the Form 990)
- Activity (NTEE)
- H99 Medical research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Medical Research
- Size band
- 8 (IRS master file code)
- Formed
- 2017
- Principal officer
- Boro Dropulic (as named on the Form 990)
- IRS ruling date
- 1 February 2020
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 5, latest 2024
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥6years on the filingsBarbara Savoldo MD PHD
≥6years on the filingsBoro Dropulic PHD MBA
≥6years on the filingsJames Kenny MBA
≥6years on the filingsJoshua Speidel PHD
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $16.5m
- Total liabilities
- $6m
- Net assets or fund balances
- $10.5m
- Contributions and grants received
- $3.8m
- Program service revenue
- $1.3m
- Grants and similar paid out
- $6k
- Employees
- 33
- Volunteers
- 14
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $6.4m | $10.3m | Deficit $3.9m |
As filed on the IRS Form 990. US dollars.